rs147324438
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_173495.3(PTCHD1):āc.517A>Gā(p.Ile173Val) variant causes a missense change. The variant allele was found at a frequency of 0.000311 in 1,209,297 control chromosomes in the GnomAD database, including 2 homozygotes. There are 147 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_173495.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000324 AC: 36AN: 111016Hom.: 0 Cov.: 23 AF XY: 0.000422 AC XY: 14AN XY: 33200
GnomAD3 exomes AF: 0.000398 AC: 73AN: 183516Hom.: 1 AF XY: 0.000471 AC XY: 32AN XY: 67946
GnomAD4 exome AF: 0.000310 AC: 340AN: 1098228Hom.: 2 Cov.: 31 AF XY: 0.000366 AC XY: 133AN XY: 363582
GnomAD4 genome AF: 0.000324 AC: 36AN: 111069Hom.: 0 Cov.: 23 AF XY: 0.000421 AC XY: 14AN XY: 33263
ClinVar
Submissions by phenotype
not provided Benign:2
PTCHD1: BS1, BS2 -
This variant is associated with the following publications: (PMID: 20844286, 23871722) -
Autism, susceptibility to, X-linked 4 Uncertain:1
- -
not specified Uncertain:1
- -
PTCHD1-related disorder Uncertain:1
The PTCHD1 c.517A>G variant is predicted to result in the amino acid substitution p.Ile173Val. This variant has been reported in at least one male patient with autism spectrum disorder/ intellectual disability and found in his unaffected mother and one of his unaffected sisters. Of note, this male patient was also heterozygous for a de novo ~1 Mb deletion encompassing the entire DPYD gene (Carter. 2010. PubMed ID: 21114665; Noor et al. 2010. PubMed ID: 20844286). In vitro experimental studies have shown that PTCHD1 protein carrying the p.Ile173Val variant is expressed at levels comparable to wild type and localizes properly to the cell membrane; however, additional experiments to assess possible impacts on protein function were not performed (Halewa et al. 2021. PubMed ID: 33856728). This variant is reported in 0.084% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, the clinical significance of this variant is uncertain at this time due to the absence of conclusive functional and genetic evidence. -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at